These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 4189687

  • 1. 3',5' cyclic adenosine monophosphate in depression and mania.
    Abdulla YH, Hamadah K.
    Lancet; 1970 Feb 21; 1(7643):378-81. PubMed ID: 4189687
    [No Abstract] [Full Text] [Related]

  • 2. Urinary adenosine 3',5'-monophosphate in the switch process from depression to mania.
    Paul MI, Cramer H, Bunney WE.
    Science; 1971 Jan 22; 171(3968):300-3. PubMed ID: 4321392
    [Abstract] [Full Text] [Related]

  • 3. Urinary cyclic AMP excretion in depression and mania. Effects of levodopa and lithium carbonate.
    Paul MI, Cramer H, Goodwin FK.
    Arch Gen Psychiatry; 1971 Apr 22; 24(4):327-33. PubMed ID: 4323949
    [No Abstract] [Full Text] [Related]

  • 4. Urinary adenosine 3',5'-monophosphate excretion in affective disorders.
    Paul MI, Ditzion BR, Pauk GL, Janowsky DS.
    Am J Psychiatry; 1970 Apr 22; 126(10):1493-7. PubMed ID: 4314024
    [No Abstract] [Full Text] [Related]

  • 5. Affective illness and cyclic-A.M.P. excretion.
    Paul MI, Ditzion BR, Janowsky DS.
    Lancet; 1970 Jan 10; 1(7637):88. PubMed ID: 4188658
    [No Abstract] [Full Text] [Related]

  • 6. [The role of cyclic AMP for the function of the peripheral and central nervous system (author's transl)].
    Müller-Oerlinghausen B, Schwabe U.
    Fortschr Neurol Psychiatr Grenzgeb; 1973 Sep 10; 41(9):509-26. PubMed ID: 4357452
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenosine 3',5'-monophosphate and mania.
    Meltzer H.
    JAMA; 1971 Jun 14; 216(11):1856-7. PubMed ID: 4325432
    [No Abstract] [Full Text] [Related]

  • 11. Urinary cyclic AMP in the switch process from depression to mania.
    Hullin RP, Salway JG, Allsopp MN, Barnes GD, Albano JD, Brown BL.
    Br J Psychiatry; 1974 Nov 14; 125():457-8. PubMed ID: 4376716
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Geisler A, Bech P, Johannesen M, Rafaelsen OJ.
    Neuropsychobiology; 1976 Nov 14; 2(4):211-20. PubMed ID: 189250
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
    Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ.
    Am J Psychiatry; 1967 Nov 14; 124(5):600-8. PubMed ID: 4383104
    [No Abstract] [Full Text] [Related]

  • 15. [Psychopharmacological agent in anxiety states].
    Dale J.
    Nord Med; 1970 Feb 19; 83(8):225-31. PubMed ID: 4910678
    [No Abstract] [Full Text] [Related]

  • 16. Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.
    Brodie HK, Murphy DL, Goodwin FK, Bunney WE.
    Clin Pharmacol Ther; 1971 Feb 19; 12(2):218-24. PubMed ID: 5554938
    [No Abstract] [Full Text] [Related]

  • 17. [Trial of G 34-586 perfusions in 43 patients].
    Margat P, Broussot T.
    Ann Med Psychol (Paris); 1969 Mar 19; 1(3):461-8. PubMed ID: 5376739
    [No Abstract] [Full Text] [Related]

  • 18. [Some current aspects of antidepressive therapy].
    Predescu V, Vianu I.
    Neurol Psihiatr Neurochir; 1967 Mar 19; 12(6):485-94. PubMed ID: 5593224
    [No Abstract] [Full Text] [Related]

  • 19. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A.
    Osp Psichiatr; 1967 Mar 19; 35(4):501-34. PubMed ID: 5607254
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.